PEDIATRICS Vol. 80 No. 6 December 1987, pp. 894-897
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aviram, M.
Right arrow Articles by Gorodischer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aviram, M.
Right arrow Articles by Gorodischer, R.

Monitoring Theophylline Therapy Using Citric Acid-Stimulated Saliva in Infants and Children With Asthma

Micha Aviram MD1, Asher Tal MD1, Zvi Ben-Zvi PhD1, and Rafael Gorodischer MD1

1 From the Division of Pediatrics and Unit of Clinical Pharmacology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Saliva stimulation is required for measurement of drugs in saliva. Chewing on a piece of paraffin, which is the method usually used for saliva stimulation, requires cooperation of the patient and, thus, is inapplicable in infants and young children. To assess the value of determining theophylline concentrations from noninvasively obtained saliva in this age group, we studied the theophylline plasma to saliva concentration ratio in citric acid-stimulated saliva. Theophylline concentration was measured in 137 simultaneously obtained paired specimens of plasma and saliva from 68 patients 2frac12 months to 14 years of age treated with theophylline for asthma (dosage 20.8 ± 5.2 mg/kg/d, mean ± SD). Saliva secretion was stimulated by placing citric acid crystals on the tongue. A strong and highly significant correlation was observed between both determinations (r = .96; P < .01). The plasma to saliva ratio was 1.78 ± 0.22 (mean ± SD), with theophylline concentrations between 3.1 and 32.1 µg/mL of plasma. The ratio of estimated to actual plasma theophylline concentrations was 1.02 ± 0.12 (mean ± SD). Interindividual coefficient of variation of plasma to saliva theophylline concentrations ratios was 12.4%; mean intraindividual coefficient of variation was 5.3%. The use of citric acid for saliva stimulation is easily applicable to infants and young children. Compared with blood drawing, stimulation of saliva secretion by citric acid is painless and noninvasive, is more readily accepted to patients, is at least as clinically relevant for theophylline determination, and allows frequent measurements of drug levels for individualization of the dosage with samples taken at home. The therapeutic concentrations range of theophylline in saliva is estimated to be between 5.6 and 11.2 µg/mL (equivalent to plasma concentrations of 10 to 20 µg/mL) in our laboratory.

Key Words: Theophylline • saliva • asthma

Submitted on November 24, 1986
Accepted on February 18, 1987




This article has been cited by other articles:


Home page
Clin. Chem.Home page
I. Kim, A. J. Barnes, J. M. Oyler, R. Schepers, R. E. Joseph Jr, E. J. Cone, D. Lafko, E. T. Moolchan, and M. A. Huestis
Plasma and Oral Fluid Pharmacokinetics and Pharmacodynamics after Oral Codeine Administration
Clin. Chem., September 1, 2002; 48(9): 1486 - 1496.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
U. Wintergerst, M. Kurowski, B. Rolinski, M. Müller, E. Wolf, H. Jaeger, and B. H. Belohradsky
Use of Saliva Specimens for Monitoring Indinavir Therapy in Human Immunodeficiency Virus-Infected Patients
Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2572 - 2574.
[Abstract] [Full Text]


Home page
JWatch GeneralHome page
USING SALIVA TO MONITOR THEOPHYLLINE THERAPY
Journal Watch (General), January 1, 1988; 1988(101): 1 - 1.
[Full Text]